0001493152-23-005663.txt : 20230221 0001493152-23-005663.hdr.sgml : 20230221 20230221163032 ACCESSION NUMBER: 0001493152-23-005663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230216 FILED AS OF DATE: 20230221 DATE AS OF CHANGE: 20230221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jain Rita CENTRAL INDEX KEY: 0001707797 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 23648664 MAIL ADDRESS: STREET 1: C/O AKEBIA THERAPEUTICS, INC. STREET 2: 245 FIRST STREET, SUITE 1100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2023-02-16 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001707797 Jain Rita C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220 HAMPTON NJ 08827 1 0 0 0 Non-Qualified Stock Option (right to buy) 42.34 2023-02-16 4 A 0 17100 0.00 A 2033-02-16 Common Stock 17100 17100 D Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. One third vests on the first, second and third anniversaries of the date of grant. /s/ Sam Martin, attorney-in-fact for Rita Jain, M.D. 2023-02-21